BEAM
Price
$21.22
Change
-$0.83 (-3.76%)
Updated
Apr 30, 6:59 PM EST
6 days until earnings call
RGNX
Price
$15.35
Change
-$0.70 (-4.36%)
Updated
Apr 30, 6:59 PM EST
Earnings call today
Ad is loading...

Analysis and predictions BEAM vs RGNX

Header iconBEAM vs RGNX Comparison
Open Charts BEAM vs RGNXBanner chart's image
Beam Therapeutics
Price$21.22
Change-$0.83 (-3.76%)
Volume$617.95K
CapitalizationN/A
REGENXBIO
Price$15.35
Change-$0.70 (-4.36%)
Volume$206.87K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs RGNX Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RGNXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. RGNX commentary
May 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongSell and RGNX is a Hold.

COMPARISON
Comparison
May 01, 2024
Stock price -- (BEAM: $21.22 vs. RGNX: $15.35)
Brand notoriety: BEAM and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 92% vs. RGNX: 52%
Market capitalization -- BEAM: $1.75B vs. RGNX: $752.81M
BEAM [@Biotechnology] is valued at $1.75B. RGNX’s [@Biotechnology] market capitalization is $752.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $566.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and RGNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 2 TA indicator(s) are bullish while RGNX’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 2 bullish, 4 bearish.
  • RGNX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -9.59% price change this week, while RGNX (@Biotechnology) price change was -3.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.52%. For the same industry, the average monthly price growth was -6.53%, and the average quarterly price growth was +1241.07%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

RGNX is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+0.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for RGNX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.75B) has a higher market cap than RGNX($753M). RGNX YTD gains are higher at: -14.485 vs. BEAM (-22.043).
BEAMRGNXBEAM / RGNX
Capitalization1.75B753M232%
EBITDAN/AN/A-
Gain YTD-22.043-14.485152%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
29
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMRGNX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
74%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 1 day ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RGNXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCAYX10.38-0.12
-1.14%
Invesco Income Advantage U.S. Fund Y
NRFAX11.28-0.15
-1.31%
Natixis AEW Global Focused Real Estate A
EQPGX21.90-0.36
-1.62%
Fidelity Advisor Equity Growth I
BMSBX13.81-0.27
-1.92%
MFS Blended Research Mid Cap Eq B
OGMNX23.05-1.09
-4.52%
Invesco Gold & Special Minerals R

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-3.76%
NTLA - BEAM
77%
Closely correlated
-2.64%
DNLI - BEAM
69%
Closely correlated
-1.03%
EDIT - BEAM
63%
Loosely correlated
-2.98%
PRME - BEAM
63%
Loosely correlated
+1.23%
VERV - BEAM
61%
Loosely correlated
-3.99%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-4.36%
AXON - RGNX
48%
Loosely correlated
+0.11%
DNLI - RGNX
44%
Loosely correlated
-1.03%
BEAM - RGNX
42%
Loosely correlated
-3.76%
SANA - RGNX
40%
Loosely correlated
-0.88%
XNCR - RGNX
40%
Loosely correlated
-0.62%
More